RED-HF
Reduction of Events with Darbepoetin alfa in Heart Failure. A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Subjects With HF and Anemia.
- Stage
- klaar
- Medicine
- darbepoëtine
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 1 January 2006
- Last Patient In
- 21 April 2012
- Last Patient Last Visit
- -
Study Director
